The essential role of recombinant phage display antibody libraries
Drug Target Review
OCTOBER 3, 2024
In 2024 alone, almost 50 antibody drug candidates are anticipated to enter regulatory review, the majority of which are mAbs. Aside from the advent of complex antibody-based drugs, the industry is facing some additional changes which are shaping drug development. Methods in Molecular Biology. 2021;291–306.
52 
Let's personalize your content